The promise of long-term treatment for neovascular age-related macular degeneration
- PMID: 38554724
- DOI: 10.1016/S0140-6736(24)00428-8
The promise of long-term treatment for neovascular age-related macular degeneration
Conflict of interest statement
I declare no competing interests.
Comment on
-
Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study.Lancet. 2024 Apr 20;403(10436):1563-1573. doi: 10.1016/S0140-6736(24)00310-6. Epub 2024 Mar 27. Lancet. 2024. PMID: 38554726 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
